Gary Musso, PhDPresident at Musso and Associates LLC
Dr. Musso is President of Musso and Associates LLC, a consulting company providing CMC technical, regulatory and compliance services. Dr. Musso received his Ph.D. in 1984 from the University of Chicago. He has worked for 35 years in the biotech industry with major leadership roles in two approved oncology drugs; VP Operation at Proteolix/Onyx (Kyprolis®- multiple myeloma) and VP Development at Praecis (Plenaxis®- prostate cancer). He has also had significant contributions to the following approved products: Vyleesi®, Angiomax®, Tymlos®, and Trulance®. In 2005, Dr. Musso started Musso and Associates LLC and has worked with over 80 companies to support development programs and M&A activities. His scientific interests are in peptides, small molecule drugs, and sophisticated drug delivery systems. Assisting smaller organizations and research institutes with effective strategies and efficient drug development processes are the focus of his company's efforts.